{"doi":"10.3410/m3-22","title":"The new face of ovarian cancer modeling: better prospects for detection and treatment","abstract":null,"journal":"F1000 Medicine Reports","year":2011,"id":615870,"datarank":0.4887144807032224,"base_score":3.258096538021482,"endowment":3.258096538021482,"self_citation_contribution":0.4887144807032224,"citation_network_contribution":0.0,"self_endowment_contribution":0.4887144807032224,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":25,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1436,"name":"Ronny Drapkin","orcid":"0000-0002-6912-6977","position":1,"is_corresponding":false},{"id":1587593,"name":"Alison M. Karst","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"The new face of ovarian cancer modeling: better prospects for detection and treatment","abstract":"Ovarian cancer has a disproportionately high mortality rate because patients typically present with late-stage metastatic disease. The vast majority of these deaths are from high-grade serous carcinoma. Recent studies indicate that many of these tumors arise from the fallopian tube and subsequently metastasize to the ovary. This may explain why such tumors have not been detected at early stage as detection efforts have been focused purely on the ovary. In keeping with this leap in understanding other advances such as the development of ex-vivo models and immortalization of human fallopian tube epithelial cells, and the use of integrated genomic analyses to identify hundreds of novel candidate oncogenes and tumor suppressors potentially involved in tumorigenesis now engender hope that we can begin to truly define the differences in pathogenesis between fallopian tube and ovarian-derived tumors. In doing so, we can hopefully improve early detection, treatment, and outcome.","is_dataset_classified":null,"base_score":3.258096538021482,"endowment":3.258096538021482,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"22076125","pmcid":"PMC3206707","openalex_id":"https://openalex.org/W2124597710","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"U01 CA152990","title":null},{"funder_name":"Canadian Institutes of Health Research","grant_id":"unidentified","title":"unidentified"},{"funder_name":"National Institutes of Health","grant_id":"5U01CA152990-09","title":"Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery"}],"total_grants":3,"fwci":3.7171,"citation_percentile":0.92243955,"influential_citations":0,"citation_trend":[{"year":2012,"count":2},{"year":2013,"count":7},{"year":2014,"count":3},{"year":2015,"count":3},{"year":2016,"count":4},{"year":2017,"count":1},{"year":2022,"count":2},{"year":2024,"count":2}],"oa_status":"bronze","license":"http://creativecommons.org/licenses/by-nc/3.0/legalcode","oa_locations":[{"url":"https://facultyopinions.com/prime/reports/m/3/22/pdf","host_type":"journal"},{"url":"https://facultyopinions.com/prime/reports/m/3/22/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3410/m3-22","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/22076125","host_type":"repository"},{"url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.288.4679","host_type":""},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3206707","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC3206707","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC3206707?pdf=render","host_type":"Europe_PMC"},{"url":"https://f1000.com/prime/reports/m/3/22/pdf","host_type":""},{"url":"http://dx.doi.org/10.3410/M3-22","host_type":""},{"url":"https://dx.doi.org/10.3410/m3-22","host_type":""}],"fields_of_study":["Ovarian cancer diagnosis and treatment","Reproductive Biology and Fertility","Cancer-related molecular mechanisms research","03 medical and health sciences","0302 clinical medicine"],"mesh_terms":[],"keywords":["Serous carcinoma","Fallopian tube","Ovarian cancer","Ovary","Serous fluid","Medicine","Stage (stratigraphy)","Carcinogenesis","Disease","Ovarian carcinoma","Bioinformatics","Ex vivo","Cancer","Oncology","Cancer research","Pathology","Biology","Internal medicine","Gynecology","In vivo","Review Article"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T21:18:32.584688Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}